Ravelcare Ltd (RAVEL) — shareholding pattern, promoter holding, financials and share price
About Ravelcare Ltd (RAVEL)
Ravelcare Ltd operates in the Personal Care industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as RAVEL and on the BSE under scrip code 544629. Its ISIN is INE0W4D01018.
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of products. [1]
Listed peers in Personal Care: Thrive Future Habitats Limited, JHS Svendgaard Laboratories Ltd, Mohini Health & Hygiene Ltd, Novateor Research Laboratories Ltd, Paramount Cosmetics (India) Ltd.
Valuation & Returns
10 Jul 2026At ₹116.65 a share on 10 Jul 2026, Ravelcare Ltd (RAVEL) was valued at a price-to-earnings ratio of 15.54x against an industry P/E of 46.1x and a price-to-book of 2.14x on a book value of ₹54.54 per share. Solomo computes return on equity of 13.78% and return on capital employed of 18.91% from filed results.
- P/E
- 15.54x
- Industry P/E
- 46.1x
- P/B
- 2.14x
- EPS (TTM)
- ₹10.48
- Book value / share
- ₹54.54
- ROE
- 13.78%
- ROCE
- 18.91%
- ROA
- 13.69%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 26.48%
- 52-week range
- ₹104 – ₹215
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Ravelcare Ltd (RAVEL) reported revenue of ₹26.95 crore, net profit of ₹5.15 crore and earnings per share of ₹7.51. That compares with revenue of ₹24.98 crore and net profit of ₹5.25 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹12.56 crore and net profit ₹1.95 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0.79 | 3.48 | 22.06 | 24.98 | 26.95 |
| Net profit (₹ cr) | -0.23 | 0.56 | 5.1 | 5.25 | 5.15 |
| EPS (₹) | -460 | 1,120 | 10,200 | 10.49 | 7.51 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 216.40% | 13.08% |
| Profit growth | - | 2.94% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 72.94% of Ravelcare Ltd (RAVEL), foreign institutional investors (FII) hold 2.57% and domestic institutional investors (DII) hold 6.28%. Market capitalisation was ₹80 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2026.
Largest disclosed public shareholders in Mar 2026: MUTHUKRISHNAN DHANDAPANI 3.31%, NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUND 2.55%, NAVBHARAT INVESTMENT TRUST-NAVBHARAT INVESTMENT OP 2.3%, VINEY GROWTH FUND 1.92%, LIGHTHOUSE CANTON SPECIAL OPPORTUNITIES FUND - I 1.63%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 72.94% | - | 2.57% | 6.28% | 27.06% |